Hand Exercises for Women With Rheumatoid Arthritis and Impaired ADL Ability: an Exploratory Trial (RAHExercise)

September 19, 2017 updated by: Eva Ejlersen Wæhrens, Parker Research Institute

Hand Exercises for Women With Rheumatoid Arthritis and Impaired ADL Ability: an Exploratory Randomized Controlled Trial

The study examines whether hand exercise therapy as an add on to a compensatory intervention program focused on joint protection, assistive devices and alternative methods of doing will improve the performance of ADL tasks requiring hand function in patients with rheumatoid arthritis (RA).

Study Overview

Study Type

Interventional

Enrollment (Actual)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Frederiksberg, Denmark, 2600
        • Copenhagen University Hospital, Frederiksberg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Female sex.
  • Age ≥ 18.
  • Diagnosis of rheumatoid arthritis (2).
  • Involvement of the hands, due to minimum one tender wrist, metacarpophalangeal (MCP) or proximal interphalangeal (PIP) joint in one of the hands.
  • Be on stable medication for at least 3 months prior to participation.
  • Self-reported decreased ability to perform personal and instrumental ADL tasks involving the hands.

Exclusion Criteria:

  • Significant osteoarthritis of the hand assessed at the initial examination by the rheumatologist
  • Hand surgery within 6 months of study participation
  • Other pain condition involving muscles and/or joints, e.g. fibromyalgia.
  • Prednisolon therapy, change in dose of biological agent or start of treatment with a new biological agent within the last 3 month before study start.
  • Inability to understand the information or to speak Danish
  • Any other condition that in the opinion of the investigator or accessing rheumatologist puts an otherwise eligible participant at increased risk by participation or otherwise make the person unfit for participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Hand Exercise
The intervention group will receive an exercise program for the hand/arm in combination with a compensatory intervention program (CIP).
Active Comparator: Compensatory Intervention Program (CIP)
The control group will receive the Compensatory Intervention Program (CIP) only.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The Assessment of Motor and Process Skills (AMPS) - the motor skill scale
Time Frame: within 2 weeks post intervention
within 2 weeks post intervention

Secondary Outcome Measures

Outcome Measure
Time Frame
The Assessment of Motor and Process Skills(AMPS) - the process skill scale
Time Frame: within 2 weeks post intervention
within 2 weeks post intervention
The Activities of Daily Living Questionnaire (ADL-Q)
Time Frame: within 2 weeks post intervention
within 2 weeks post intervention
Health Assessment Questionnaire (HAQ)
Time Frame: within 2 weeks post intervention
within 2 weeks post intervention
Overall disease activity (DAS-28)
Time Frame: within 2 weeks post intervention
within 2 weeks post intervention
Grip strength
Time Frame: within 2 weeks post intervention
within 2 weeks post intervention

Other Outcome Measures

Outcome Measure
Time Frame
Ultrasound Doppler
Time Frame: within 2 weeks post intervention
within 2 weeks post intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (Actual)

March 1, 2016

Study Completion (Actual)

May 1, 2016

Study Registration Dates

First Submitted

May 2, 2014

First Submitted That Met QC Criteria

May 14, 2014

First Posted (Estimate)

May 16, 2014

Study Record Updates

Last Update Posted (Actual)

September 20, 2017

Last Update Submitted That Met QC Criteria

September 19, 2017

Last Verified

September 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rheumatoid Arthritis

Clinical Trials on Hand Exercise

3
Subscribe